当前位置: X-MOL首页全球导师 国内导师 › 刘国恩

个人简介

刘国恩,经济学博士,北京大学国家发展研究院教授、北京大学全球健康发展研究院院长、北大大学中国卫生经济研究中心主任。刘国恩教授目前担任国际健康经济学英文一流期刊《Health Economics》副主编;国务院国家医改专家咨询委员会委员;《中美健康二轨对话》的中方召集人;中国药物经济学专业委员会主任委员等职。2020年初新冠爆发后,入选全国新冠专家委员会委员;担任国家医疗保障局医保目录调整的药物经济学测算专家组组长(2020-2022)。2014年入选教育部“长江学者奖励计划”特聘教授;2019年荣获“中国最受关注的医改专家”,2021年当选中国药学会2021年“最美科技工作者”。 刘国恩教授曾经执教美国南加州大学、北卡大学教堂山分校(获终身职);中国留美经济学会主席(2005-2006);北京大学光华管理学院经济学教授(2003-2013),北京大学国家发展研究院学术委员会主任(2013-2022)。刘国恩教授带领的科研团队承担过国内外重要科研工作,其中包括国家自然科学基金、世界银行、WHO、国家卫健委、工业与信息部等立项项目,重点研究国家医改政策、药物经济学评估、公立医院改革、全球医院管理调查、中国居民慢性病和经济发展等课题。2017年《基于世界管理调查的中国医院管理干预实验》获得国家自然科学基金支持,通过《世界管理调查》的双盲访谈方法,首次构建了中国医院管理调查的双盲数据库,为分析中国医院管理在全球坐标下的定位提供了科学依据。2019年,获得国家自然科学基金重点项目《精准健康扶贫的经济学实验:基于四川凉山的干预研究》,该课题在过去两年虽然受到疫情对实地调查的影响,团队成员群策群力,在地方政府的高度支持下,目前加速推进,按计划在2023年底顺利完成该课题。2020年承担了国家“十四五”社会办医的课题;2022年完成了国家高端智库特邀课题“国家疫情防控的成本-收益评估”,得到中央领导重要批示,并通报表扬。 现任: 全球健康发展研究院院长、教育部经济学长江学者特聘教授、北大中国卫生经济研究中心主任

研究领域

健康与发展经济学,国家医疗体制改革,以及医药经济学

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Butt T, Liu GG., et al., “Taking stock of cost-effectiveness analysis of healthcare in China,” BMJ Global Health, forthcoming, 2019. Shang P, Liu GG et al., “Association Between Medication Adherence and 1-year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China,” JAHA, forthcoming, 2019. Wang Pei, Liu GG., et al. “Valuation of EQ-5D-5L Health States: A Comparison of Seven Asian Populations,” Expert Review of Pharmacoeconomics & Outcomes Research, forthcoming, 2019. Shi J, Yao Y., and Liu GG., “Modeling Individual Healthcare Expenditures in China: Evidence to Assist Payment Reform in Public Insurance,” Health Economics, 2018, 27(12):1945-1962. Jin XJ., Gerstein HC, Liu GG., et al. “Minimally important difference and predictors of change in quality of life as measured using the EQ-5D among Chinese Type 2 Diabetic Patients: A community-based survey in China,” Diabetes/Metabolism Research and Reviews, 2018, July. Li Hong, Liu GG., et al., “Recent Pricing Negotiations on Innovative Medicines Pilot in China: Experiences, Implications, and Suggestions,” Value in Health Regional Issues, 2018: 133-137. Jin X, Liu GG, Gerstein HC, Levine MAH, Steve K, Guan H, Li H, Xie F, “Item reduction and validation of the Chinese version of diabetes quality-of-life measure (DQOL),” Health Qual Life Outcomes, 2018, 16:78 崔宇杰,姚瑶,刘国恩,杨茂睿,“体检改变了人们的就医行为吗?”《保险研究》,2018(02):53-64. 姚瑶,刘国恩,“健康与卫生服务利用的不平等:来自省级数据的证据,”《中国卫生经济》,2018(04) 秦雪征,周钦,刘国恩,“不患寡而患不均?相对生活水平对居民心理健康的影响”,《经济理论与经济管理》,2018 陆方文,刘国恩,李辉文,“子女性别与父母幸福感”,《经济研究》,2017,第十期:173-188. Hu XF, Liu GG., and Fan M., “Long-Term Effects of Famine on Chronic Diseases: Evidence from China’s Great Leap Forward Famine,” Health Economics, 2017, 26(7): 922–936. An RP, Liu GG., et al., “Dietary habits and cognitive impairment risk among oldest-old Chinese," Journal of Gerontology: Social Sciences, 2017, forthcoming. Liu GG., Vortherms SA., and Hong XZ, “China’s health reform update,” Annual Review of Public Health, 2017, 38: 431-448. Liu GG., “Building A National Health System,” China Economic Quarterly, 2017, 21(1): 16-23. Liu GG., et al., “How Much Does Social Status Matter to Longevity? – Evidence from China’s Academician Election,” Health Economics, 2017, 26(3):292-304. Luo N., Liu GG. Li M., Guan H, Jin X, and Rand-Hendriksen K., “Estimating an EQ-5D-5L value set for China,” Value in Health, 2017 Apr;20(4):662-669. An RP and Liu GG., “Cognitive Impairment and Mortality among the Oldest-old Chinese," International Journal of Geriatric Psychiatry, 2016, 31: 1345–1353. Hu XF, Liu GG., and Fan M., “Long-Term Effects of Famine on Chronic Diseases: Evidence from China’s Great Leap Forward Famine,” Health Economics, 2016, Jun 16. doi: 10.1002/hec.3371. Stevens W., Liu GG., et al., “Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China,” BMC Health Services Research, 2016, 16(1):175. Liu GG., Xue XD., Yu C., Wang YF., “How does social capital matter to the health status of older adults? Evidence from the China Health and Retirement Longitudinal Survey,” Economics and Human Biology, 2016, 22: 177-189. Zhou Q., Liu GG., Krumholz S., “Is Chinese National Health Insurance Effective in the Face of Severe Illness? A Perspective from Health Service Utilization and Economic Burden,” Social Indicators Research, 2016, 2016: 1-23. Fan M, Lei Z, and Liu GG., “Discounting of Medical Savings Accounts,” American J of Health Economics, 2016(4): 161-183. Xuejing Jin., Liu GG., et al., “Is bad living better than good death? Impact of demographic and cultural factors on health state preference,” Quality of Life Research, 2016, 25(4): 979-986. Zhou Qin, Liu GG. et al., “The Impact of Health Insurance Cost-Sharing Method on Healthcare Utilization in China,” China Journal of Social Work, 2016, 9(1): 38-61. 何泱泱、刘国恩、徐程, “中国职业隔离与性别工资差异的变化趋势研究,” 《经济科学》,2016年第4期。 刘国恩、官海静,“分级诊疗与全科诊所:中国医疗供给侧改革的关键,”《中国全科医学》,2016:2619-2624. Pan J., Lei XY, and Liu GG., “Health Insurance and Health Status: Exploring the Causal Effect from A Policy Intervention,” Health Economics, 2016, 25:1389-1402. Li Q, Liu GG., and Zang WB, “The Health of Left-behind Children in Rural China,” China Economic Review, 2015, 36:367-376. Wang P, Li MH, Liu GG, Thumboo J., and Luo N, “Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese,” European J of Health Economics, 2015 (16): 857–863. Xu J., Liu GG. et al., “A comparison of outpatient healthcare expenditures between public and private medical institutions in urban China: an instrumental variable approach,” Health Economics, 2015(24): 270-279. 官海静,刘国恩,“中国城乡居民生命质量的比较研究,”《中国卫生经济》,2015(2);5-12. Liu GG., Chen YQ, and Qin XZ., “Transforming rural healthcare through information technology: an interventional study in China,” Health Policy and Planning, 2014 (8): 975-985. Liu GG., Wu HY., Li MH., Gao C., and Luo N., “Chinese time trade-off values for EQ-5D health states,” Value in Health, 2014 (17): 597–604. 周钦,刘国恩,“健康冲击:现行医疗保险制度究竟发挥了什么作用?”《经济评论》,2014(6)。 陆方文,高晨,徐菲,刘国恩,熊先军,“按人头付费与开放式首诊改革:基于城居保入户调查分析,”《中国卫生经济》,2014年6期。 潘杰,刘国恩,尹庆双,“医疗体制管办分开与服务供给,”《经济学报》,2014 (1):33-50. Liu GG and Krumholz S., “Economics of health transition in China,” The Oxford Companion to the Economics of China, edited by Ravi Kanbur et al., Oxford University Press, 2014. Qin XQ, Pan J, and Liu GG., “Does participating in health insurance benefit the migrant workers in China? an empirical investigation,” China Economic Review, 2014 (30): 263-278. DiBonaventura M, Yuan Y, Lescrauwaet B, L'Italien G, Liu GG., “Multicountry burden of chronic hepatitis C viral infection among those aware of their diagnosis: A patient survey,” PLOS ONE, Jan 21, 2014. 黄源,刘国恩,刘跃华等,“精神分裂症的疾病经济负担:基于广州医保数据的分析,”《中国卫生经济》,2014(5): 62-65. Wu J., Xu J., Liu GG., “Pharmaceutical pricing: an empirical study of market competition in Chinese hospitals,” PharmacoEconomics, 2014 (32):293-303. 兰烯,刘国恩,李林,“医疗机构产权性质对医疗服务质量的影响,”《中国经济问题》,2014(2):67-78. Gao C., Xu F., Liu GG., “Payment reform and changes in health care in China,” Social Science & Medicine, 2014 (111): 10-16. Chen G, Liu GG., and Xu F., "The impact of the urban resident basic medical insurance in China on health services utilization," PharmacoEconomics, 2014 (32): 277-292. 赵绍阳,臧文斌,傅十和,刘国恩,“强制医保制度下无保险人群的健康状况研究,”《经济研究》,2013 (7): 118-131. 刘国恩,“践行三中全会改革要义: 深化国家医改,谨防误读盲区,”《经济科学》,2013年第六期。 Li H., Liu GG., Glaetzer C., “Financing innovative medicines in China: the role of commercial health insurance,” Chinese Studies, 2013 (3): 128-133. Pan J., Liu GG., and Gao C., “How does separating government regulatory and operational control of public hospitals matter to healthcare supply?” China Economic Review, 2013 (27):1–14. 伍红艳,刘国恩,“生命质量量表不同计分方法对评价结果的影响,”《中国卫生经济》,2013 (8). 刘国恩,“转变经济发展方式靠什么:论两只看不见的手,”《比较》,2013(3):130-144. Lai W, Hu S., Hou J, Liu GG., “A novel estimation of the impact of treatment with entecavir on long-term mortality, morbidity and healthcare costs of chronic hepatitis B in China,” Value in Health Regional Issues, 2013 (2):48-56. 樊敏杰,刘国恩,李林, “医疗机构产权性质对医疗费用的影响,”《中国经济问题》,2013 (5):59-69. 刘国恩,官海静,高晨,“中国社会办医的现状分析,”《中国卫生政策研究》,2013(6):41-46. Pan J, Qin X, Liu GG., "The impact of body size on urban employment: evidence from China." China Economic Review, 2013 (27): 249-263 Luo N, Li M, Liu GG et al., “Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approach,” Quality of Life Research, 2013(4): 885–890. 潘杰,雷晓燕,刘国恩,“医疗保险促进健康吗?”《经济研究》,2013 (4): 130-142. Qin XZ and Liu GG., “Does the U.S. healthcare safety net discourage private insurance coverage?” European J of Health Economics, 2013 (3): 457-469. Liu YJ, Xue YJ, Liu GG., and Ma AX., "Development of foreign invested hospitals in China: obstacles and coping strategies," Journal of Hospital Administration, 2013(2): 142-150. Zhao ZY, Liu GG., et al., “Hospital costs of adverse events in patients with metastatic colorectal cancer,” Journal of Cancer Therapy, 2013 (4): 153-158. 符一男,刘国恩,朱琳,马爱霞,“七价肺炎结合疫苗的药物经济学评价,”《中国卫生经济》, 2013(1). 官海静,刘国恩,熊先军, “城镇居民基本医疗保险对住院服务利用公平性的影响,”《中国卫生经济》,2013(1). 臧文斌,赵绍阳,刘国恩,“城镇基本医疗保险中逆向选择的检验,”《经济学季刊》,2012, 12(1):47-70. 薛新东,刘国恩,“社会资本决定健康状况吗?”《财贸经济》,2012(8):113-121 。 Liu GG et al., “The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan,” Value in Health, 2012, 15(1). 徐程,尹庆双,刘国恩,“健康经济学研究新进展,”《经济学动态》,2012(9):120-127. 藏文斌,刘国恩,徐菲,“中国城镇基本医疗保险对家庭消费的影响,”《经济研究》,2012(7):75-85。 秦学征,刘国恩, “医疗保险对劳动力市场的影响:综述分析,”《经济学动态》, 2011(12):116-121。 Pan Jay and Liu GG, “The determinants of Chinese provincial government health expenditures: evidence from 2002-2006 data,” Health Economics, 2012(21): 757–777. 潘杰,秦学征,刘国恩,“体形对城市劳动力就业的影响,” 《南开经济研究》,2011; 刘国恩,蔡春光, 李林, “中国老人医疗保障与医疗服务需求的实证分析,”《经济研究》,2011(3): 95-107. 林莞娟,刘国恩等,“中国城镇居民基本医疗保险实施与评价,”《经济学报》,2010. 甘犁,刘国恩,马双, “基本医疗保险对促进家庭消费的影响,”《经济研究》,2010. 王鹏,刘国恩, “健康人力资本与性别工资差异,”《南方经济》,2010年(9):73-84. Qiu Y., Fu A, Liu GG., and Christensen D., “Healthcare Costs of Atypical Antipsychotic Use for Patients with Bipolar Disorder in a Medicaid Program,” Applied Health Economics and Health Policy, 2010, 8(3):167-177. Liu GG., Zhang SF ,and Zhang ZY., Investing in Human Capital for Economic Development in China, published by World Scientific, 2010. Liu GG., Fukuda T., Lee CE. et al., “Evidenced-based Decision Making on Medical Technologies in China, Japan, and Singapore,” Value in Health, 2009, 12(3): S12 - S17. 刘国恩, “全民医疗保障与保民生促增长,” 《理论前沿》, 2009, 16: 5-8. Liu GG., Li L., Hou X. et al., “The role of for-profit hospitals in medical expenditures: evidence from aggregate data in China,” China Economic Review, 2009, 20: 625-633. Lin W., Liu GG., and Chen G., “The Urban Resident Basic Medical Insurance: a landmark reform towards universal coverage in China,” Health Economics, 2009, 18:S83-S96. Liu GG., “Beijing’s perspective: the internal debate on health care reform,” published by the Center for Strategy and International Studies (CSIS), Washington DC., 2009. 刘国恩,唐燕,刘立藏,“城镇职工医疗保险政策研究:个人账户与医疗支出,”《财经科学》,2009. 李林,刘国恩,“我国营利性医院发展与医疗费用研究,”《管理世界》,2008, 10: 53-63. Liu GG., Eggleston K., and Hu TW., “Emerging health economics and outcomes research in Asian Pacific Region,” Value in Health, 2008, 11:s1-s2. Liu GG., Dow W., Fu AZ., Akin J., and Lance P., “Income productivity in China: on the role of health,” Journal of Health Economics, 2008, 22: 22-44.

学术兼职

学术兼职 Associate Editor, Health Economics, 2013 – 副主编,《经济学》(季刊),2013 – Co-Editor, Value in Health(国际药物经济学会official journal), 2001 – 2012 联合国《可持 续发展方案联盟》 – 健康组联席主席,The UN Sustainable Development Solutions Network (SDSN)led by Jeffrey Sachs, 2013 – 主席,中国留美经济学会 (Chinese Economists Society, 2004-2005)

推荐链接
down
wechat
bug